Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 29 Jan 2024 |
| Trading by management and close relations of management | 29 Jan 2024 |
| All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen | 26 Jan 2024 |
| South Korean merger approval granted | 20 Dec 2023 |
| Novozymes' updated financial calendar | 13 Dec 2023 |